nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2D6—Vinorelbine—ovarian cancer	0.0788	0.183	CbGbCtD
Efavirenz—CYP3A4—Topotecan—ovarian cancer	0.0712	0.165	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—ovarian cancer	0.0618	0.143	CbGbCtD
Efavirenz—CYP2C9—Paclitaxel—ovarian cancer	0.0606	0.14	CbGbCtD
Efavirenz—CYP3A4—Vinorelbine—ovarian cancer	0.0501	0.116	CbGbCtD
Efavirenz—CYP3A4—Paclitaxel—ovarian cancer	0.0352	0.0815	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—ovarian cancer	0.0299	0.0691	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—ovarian cancer	0.0255	0.059	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—ovarian cancer	0.019	0.0439	CbGbCtD
Efavirenz—Cough—Docetaxel—ovarian cancer	0.000367	0.000646	CcSEcCtD
Efavirenz—Insomnia—Paclitaxel—ovarian cancer	0.000366	0.000644	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—ovarian cancer	0.000365	0.000642	CcSEcCtD
Efavirenz—Convulsion—Docetaxel—ovarian cancer	0.000364	0.000641	CcSEcCtD
Efavirenz—Paraesthesia—Paclitaxel—ovarian cancer	0.000363	0.00064	CcSEcCtD
Efavirenz—Hypertension—Docetaxel—ovarian cancer	0.000363	0.000639	CcSEcCtD
Efavirenz—Infestation—Epirubicin—ovarian cancer	0.000363	0.000639	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—ovarian cancer	0.000363	0.000639	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—ovarian cancer	0.000363	0.000639	CcSEcCtD
Efavirenz—Dyspnoea—Paclitaxel—ovarian cancer	0.000361	0.000635	CcSEcCtD
Efavirenz—Somnolence—Paclitaxel—ovarian cancer	0.00036	0.000633	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00036	0.000633	CcSEcCtD
Efavirenz—Arthralgia—Docetaxel—ovarian cancer	0.000358	0.00063	CcSEcCtD
Efavirenz—Chest pain—Docetaxel—ovarian cancer	0.000358	0.00063	CcSEcCtD
Efavirenz—Myalgia—Docetaxel—ovarian cancer	0.000358	0.00063	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—ovarian cancer	0.000357	0.000629	CcSEcCtD
Efavirenz—Nausea—Vinorelbine—ovarian cancer	0.000357	0.000629	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—ovarian cancer	0.000356	0.000628	CcSEcCtD
Efavirenz—Dyspepsia—Paclitaxel—ovarian cancer	0.000356	0.000627	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000355	0.000626	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000355	0.000625	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—ovarian cancer	0.000354	0.000622	CcSEcCtD
Efavirenz—Decreased appetite—Paclitaxel—ovarian cancer	0.000352	0.000619	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—ovarian cancer	0.00035	0.000616	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00035	0.000616	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000349	0.000615	CcSEcCtD
Efavirenz—Fatigue—Paclitaxel—ovarian cancer	0.000349	0.000614	CcSEcCtD
Efavirenz—Sweating—Epirubicin—ovarian cancer	0.000348	0.000612	CcSEcCtD
Efavirenz—Pain—Paclitaxel—ovarian cancer	0.000346	0.000609	CcSEcCtD
Efavirenz—Constipation—Paclitaxel—ovarian cancer	0.000346	0.000609	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—ovarian cancer	0.000346	0.000609	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—ovarian cancer	0.000346	0.000609	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000344	0.000605	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000343	0.000604	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—ovarian cancer	0.00034	0.000599	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000339	0.000598	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—ovarian cancer	0.000338	0.000594	CcSEcCtD
Efavirenz—Shock—Docetaxel—ovarian cancer	0.000337	0.000594	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—ovarian cancer	0.000336	0.000592	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—ovarian cancer	0.000336	0.000591	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—ovarian cancer	0.000336	0.000591	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—ovarian cancer	0.000336	0.000591	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—ovarian cancer	0.000336	0.000591	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—ovarian cancer	0.000335	0.000589	CcSEcCtD
Efavirenz—Feeling abnormal—Paclitaxel—ovarian cancer	0.000333	0.000587	CcSEcCtD
Efavirenz—Skin disorder—Docetaxel—ovarian cancer	0.000333	0.000586	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000333	0.000586	CcSEcCtD
Efavirenz—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000331	0.000582	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—ovarian cancer	0.00033	0.000581	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000329	0.000579	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—ovarian cancer	0.000327	0.000576	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—ovarian cancer	0.000327	0.000576	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—ovarian cancer	0.000326	0.000575	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—ovarian cancer	0.000326	0.000573	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—ovarian cancer	0.000324	0.00057	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—ovarian cancer	0.000322	0.000566	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—ovarian cancer	0.000322	0.000566	CcSEcCtD
Efavirenz—Urticaria—Paclitaxel—ovarian cancer	0.000321	0.000566	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—ovarian cancer	0.000321	0.000565	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—ovarian cancer	0.00032	0.000563	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—ovarian cancer	0.00032	0.000563	CcSEcCtD
Efavirenz—Abdominal pain—Paclitaxel—ovarian cancer	0.00032	0.000563	CcSEcCtD
Efavirenz—Body temperature increased—Paclitaxel—ovarian cancer	0.00032	0.000563	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—ovarian cancer	0.000319	0.000562	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000317	0.000559	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—ovarian cancer	0.000315	0.000554	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—ovarian cancer	0.000314	0.000552	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000312	0.00055	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—ovarian cancer	0.00031	0.000546	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—ovarian cancer	0.000308	0.000542	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—ovarian cancer	0.000308	0.000542	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—ovarian cancer	0.000306	0.000538	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—ovarian cancer	0.000305	0.000537	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—ovarian cancer	0.000304	0.000536	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—ovarian cancer	0.000304	0.000534	CcSEcCtD
Efavirenz—Flushing—Epirubicin—ovarian cancer	0.000302	0.000532	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—ovarian cancer	0.000302	0.000532	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—ovarian cancer	0.000302	0.000532	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—ovarian cancer	0.000302	0.000531	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—ovarian cancer	0.000301	0.00053	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—ovarian cancer	0.0003	0.000528	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—ovarian cancer	0.000298	0.000525	CcSEcCtD
Efavirenz—Hypersensitivity—Paclitaxel—ovarian cancer	0.000298	0.000525	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000297	0.000524	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—ovarian cancer	0.000297	0.000522	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000296	0.000521	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000296	0.000521	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—ovarian cancer	0.000296	0.000521	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—ovarian cancer	0.000295	0.00052	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—ovarian cancer	0.000295	0.00052	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—ovarian cancer	0.000294	0.000518	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—ovarian cancer	0.000293	0.000517	CcSEcCtD
Efavirenz—Pain—Docetaxel—ovarian cancer	0.000293	0.000516	CcSEcCtD
Efavirenz—Constipation—Docetaxel—ovarian cancer	0.000293	0.000516	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—ovarian cancer	0.000291	0.000512	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—ovarian cancer	0.00029	0.000511	CcSEcCtD
Efavirenz—Asthenia—Paclitaxel—ovarian cancer	0.00029	0.000511	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—ovarian cancer	0.000288	0.000507	CcSEcCtD
Efavirenz—Pruritus—Paclitaxel—ovarian cancer	0.000286	0.000504	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—ovarian cancer	0.000285	0.000501	CcSEcCtD
Efavirenz—Erythema—Epirubicin—ovarian cancer	0.000283	0.000499	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—ovarian cancer	0.000283	0.000499	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—ovarian cancer	0.000283	0.000498	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—ovarian cancer	0.000282	0.000496	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—ovarian cancer	0.000281	0.000494	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00028	0.000494	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—ovarian cancer	0.00028	0.000492	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—ovarian cancer	0.00028	0.000492	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—ovarian cancer	0.000279	0.000492	CcSEcCtD
Efavirenz—Tension—Epirubicin—ovarian cancer	0.000278	0.00049	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—ovarian cancer	0.000278	0.000489	CcSEcCtD
Efavirenz—Diarrhoea—Paclitaxel—ovarian cancer	0.000277	0.000487	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—ovarian cancer	0.000275	0.000485	CcSEcCtD
Efavirenz—Back pain—Epirubicin—ovarian cancer	0.000274	0.000483	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—ovarian cancer	0.000273	0.000481	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—ovarian cancer	0.000272	0.000479	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000271	0.000478	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—ovarian cancer	0.000271	0.000477	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—ovarian cancer	0.000271	0.000477	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—ovarian cancer	0.000269	0.000474	CcSEcCtD
Efavirenz—Dizziness—Paclitaxel—ovarian cancer	0.000268	0.000471	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—ovarian cancer	0.000267	0.00047	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—ovarian cancer	0.000266	0.000469	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—ovarian cancer	0.000263	0.000463	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—ovarian cancer	0.000262	0.000462	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—ovarian cancer	0.000262	0.000462	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—ovarian cancer	0.000262	0.000461	CcSEcCtD
Efavirenz—Agitation—Epirubicin—ovarian cancer	0.00026	0.000459	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—ovarian cancer	0.000258	0.000455	CcSEcCtD
Efavirenz—Tension—Doxorubicin—ovarian cancer	0.000257	0.000453	CcSEcCtD
Efavirenz—Vomiting—Paclitaxel—ovarian cancer	0.000257	0.000453	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—ovarian cancer	0.000257	0.000452	CcSEcCtD
Efavirenz—Malaise—Epirubicin—ovarian cancer	0.000256	0.00045	CcSEcCtD
Efavirenz—Rash—Paclitaxel—ovarian cancer	0.000255	0.000449	CcSEcCtD
Efavirenz—Dermatitis—Paclitaxel—ovarian cancer	0.000255	0.000449	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—ovarian cancer	0.000255	0.000448	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—ovarian cancer	0.000255	0.000448	CcSEcCtD
Efavirenz—Syncope—Epirubicin—ovarian cancer	0.000254	0.000447	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—ovarian cancer	0.000254	0.000447	CcSEcCtD
Efavirenz—Headache—Paclitaxel—ovarian cancer	0.000253	0.000446	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—ovarian cancer	0.000253	0.000445	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—ovarian cancer	0.00025	0.000441	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—ovarian cancer	0.000249	0.000439	CcSEcCtD
Efavirenz—Cough—Epirubicin—ovarian cancer	0.000247	0.000435	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—ovarian cancer	0.000247	0.000435	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—ovarian cancer	0.000246	0.000433	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—ovarian cancer	0.000246	0.000432	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—ovarian cancer	0.000245	0.000431	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000243	0.000428	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—ovarian cancer	0.000243	0.000427	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—ovarian cancer	0.000242	0.000427	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—ovarian cancer	0.000241	0.000425	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—ovarian cancer	0.000241	0.000425	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—ovarian cancer	0.000241	0.000425	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—ovarian cancer	0.000241	0.000424	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—ovarian cancer	0.00024	0.000423	CcSEcCtD
Efavirenz—Nausea—Paclitaxel—ovarian cancer	0.00024	0.000423	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00024	0.000422	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—ovarian cancer	0.000238	0.00042	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—ovarian cancer	0.000236	0.000416	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—ovarian cancer	0.000236	0.000415	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—ovarian cancer	0.000236	0.000415	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—ovarian cancer	0.000235	0.000414	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—ovarian cancer	0.000235	0.000413	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—ovarian cancer	0.000233	0.000411	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—ovarian cancer	0.000232	0.000408	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—ovarian cancer	0.00023	0.000406	CcSEcCtD
Efavirenz—Cough—Doxorubicin—ovarian cancer	0.000229	0.000403	CcSEcCtD
Efavirenz—Shock—Epirubicin—ovarian cancer	0.000228	0.000401	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—ovarian cancer	0.000227	0.0004	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—ovarian cancer	0.000227	0.000399	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—ovarian cancer	0.000227	0.000399	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—ovarian cancer	0.000226	0.000399	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—ovarian cancer	0.000226	0.000399	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—ovarian cancer	0.000226	0.000397	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—ovarian cancer	0.000225	0.000396	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—ovarian cancer	0.000224	0.000394	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—ovarian cancer	0.000223	0.000393	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—ovarian cancer	0.000223	0.000393	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—ovarian cancer	0.000223	0.000393	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—ovarian cancer	0.000222	0.000392	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000222	0.00039	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—ovarian cancer	0.000221	0.000388	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—ovarian cancer	0.00022	0.000388	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—ovarian cancer	0.000218	0.000384	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—ovarian cancer	0.000218	0.000384	CcSEcCtD
Efavirenz—Rash—Docetaxel—ovarian cancer	0.000216	0.000381	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—ovarian cancer	0.000216	0.00038	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—ovarian cancer	0.000216	0.00038	CcSEcCtD
Efavirenz—Headache—Docetaxel—ovarian cancer	0.000215	0.000378	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000211	0.000371	CcSEcCtD
Efavirenz—Shock—Doxorubicin—ovarian cancer	0.000211	0.000371	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—ovarian cancer	0.00021	0.00037	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00021	0.000369	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—ovarian cancer	0.000209	0.000368	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—ovarian cancer	0.000209	0.000368	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—ovarian cancer	0.000208	0.000366	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—ovarian cancer	0.000208	0.000366	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000207	0.000364	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—ovarian cancer	0.000206	0.000363	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—ovarian cancer	0.000206	0.000362	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—ovarian cancer	0.000204	0.000359	CcSEcCtD
Efavirenz—Nausea—Docetaxel—ovarian cancer	0.000204	0.000359	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—ovarian cancer	0.000204	0.000358	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—ovarian cancer	0.000201	0.000354	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.0002	0.000352	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—ovarian cancer	0.000199	0.000351	CcSEcCtD
Efavirenz—Pain—Epirubicin—ovarian cancer	0.000198	0.000348	CcSEcCtD
Efavirenz—Constipation—Epirubicin—ovarian cancer	0.000198	0.000348	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000195	0.000343	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—ovarian cancer	0.000194	0.000341	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—ovarian cancer	0.000192	0.000338	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—ovarian cancer	0.000191	0.000336	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—ovarian cancer	0.000191	0.000336	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—ovarian cancer	0.00019	0.000335	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000189	0.000333	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—ovarian cancer	0.000188	0.000332	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—ovarian cancer	0.000186	0.000328	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000185	0.000325	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—ovarian cancer	0.000185	0.000325	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—ovarian cancer	0.000184	0.000324	CcSEcCtD
Efavirenz—Pain—Doxorubicin—ovarian cancer	0.000183	0.000322	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—ovarian cancer	0.000183	0.000322	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—ovarian cancer	0.000183	0.000322	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—ovarian cancer	0.000183	0.000322	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—ovarian cancer	0.000176	0.000311	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000175	0.000308	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—ovarian cancer	0.00017	0.0003	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—ovarian cancer	0.00017	0.000299	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—ovarian cancer	0.000169	0.000298	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—ovarian cancer	0.000169	0.000298	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—ovarian cancer	0.000166	0.000292	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—ovarian cancer	0.000164	0.000288	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—ovarian cancer	0.000158	0.000279	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—ovarian cancer	0.000158	0.000278	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—ovarian cancer	0.000154	0.00027	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—ovarian cancer	0.000153	0.000269	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—ovarian cancer	0.000151	0.000267	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—ovarian cancer	0.000147	0.000259	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—ovarian cancer	0.000146	0.000258	CcSEcCtD
Efavirenz—Rash—Epirubicin—ovarian cancer	0.000146	0.000257	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—ovarian cancer	0.000146	0.000257	CcSEcCtD
Efavirenz—Headache—Epirubicin—ovarian cancer	0.000145	0.000255	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—ovarian cancer	0.000142	0.000249	CcSEcCtD
Efavirenz—Nausea—Epirubicin—ovarian cancer	0.000137	0.000242	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—ovarian cancer	0.000136	0.00024	CcSEcCtD
Efavirenz—Rash—Doxorubicin—ovarian cancer	0.000135	0.000238	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—ovarian cancer	0.000135	0.000237	CcSEcCtD
Efavirenz—Headache—Doxorubicin—ovarian cancer	0.000134	0.000236	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—ovarian cancer	0.000127	0.000224	CcSEcCtD
